Description

van de Stadt et al reported a clinical prediction rule for a seropositive patient with arthralgia. This can help determine the risk of the patient progressing to arthritis. The authors are from Jan van Breemen Research Institute/Reade and VU Iniversity in Amsterdam.


Patient selection: seropositive arthralgia without arthritis; either rheumatoid factor IgM (RF) or anticyclic citrullinated peptide (aCCP) antibodies positive

 

Parameters:

(1) family history of rheumatoid arthritis in a first degree relative

(2) alcohol use

(3) duration of symptoms in months

(4) intermittent symptoms

(5) arthralgia in upper and lower extremities

(6) pain on 10 cm VAS

(7) morning stiffness in hours

(8) history of swollen joints

(9) antibody results

 

Parameter

Finding

Points

family history RA

absent

0

 

present

1

alcohol use

no

1

 

yes

0

duration of symptoms

< 12 months

1

 

>= 12 months

0

intermittent symptoms

absent

0

 

present

1

arthralgia in upper and lower extremities

no

0

 

yes

1

pain on VAS scale

< 50 mm (5 cm)

0

 

>= 50 mm (5 cm)

2

morning stiffness

< 1 hours

0

 

>= 1 hours

1

history of swollen joints

no

0

 

yes

1

antibody results

IgM RF positive; aCCP negative

0

 

IgM RF negative; aCCP low positive

2

 

IgM RF negative; aCCO high positive

3

 

both positive

4

 

where:

• A high positive aCCP was >= 3 times the upper limit of the reference range;

• A low positive aCCP was 1.01 to 2.99 times the upper limit of the reference range.

 

score =

= SUM(points for all 9 parameters)

 

Interpretation:

• minimum score: 0

• maximum score: 13

• The higher the score the greater the risk of developing rheumatoid arthritis.

 

Score

Risk

Percent Arthritis in 5 Years

0 to 4

low

12%

5 or 6

intermediate

43%

7 to 13

high

81%

 

Performance:

• The area under the ROC curve at 5 years was 0.82.


To read more or access our algorithms and calculators, please log in or register.